Development of targeted therapy therapeutics to sensitize triple-negative breast cancer chemosensitivity utilizing bacteriophage phi29 derived packaging RNA

Abstract Background To date, triple-negative breast cancer (TNBC) treatment options are limited because of the loss of target receptors and, as a result, are only managed with chemotherapy. What is worse is that TNBC is frequently developing resistance to chemotherapy. By using small interfering RNA...

Повний опис

Бібліографічні деталі

Автори:	Long Zhang, Chaofeng Mu, Tinghong Zhang, Dejun Yang, Chenou Wang, Qiong Chen, Lin Tang, Luhui Fan, Cong Liu, Jianliang Shen, Huaqiong Li
Формат:	Artigo
Мова:	Inglês
Опубліковано:	BMC 2021-01-01
Серія:	Journal of Nanobiotechnology
Предмети:	RNA nanoparticles XBP1 siRNA TNBC Chemoresistance
Онлайн доступ:	https://doi.org/10.1186/s12951-020-00758-4
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!